South Korea[韩国药品]
|
FABAGAL Inj.(Agalsidase Beta) |
FABAGALInj.(AgalsidaseBeta)initiateddevelopmentsince2003withitsmarketingauthorizationgainedfromKFDAinJanuary2014.ItisadesignatedorphandrugforFabry'sDiseasepatientsasalongtermenzymereplacemen.. |
录入者:admin 发表于:2014-11-05
查阅全文... |
CLOTINAB(Abciximab) |
Withitsinitialdevelopmentstartedin2001,byDecember2006,marketingauthorizationwasgainedbyKFDAandwaslaunchedinthemarketbyendof2007.AlthoughthemarketsizeofCLOTINABissmall,itservesagreatsignificancea.. |
录入者:admin 发表于:2014-11-05
查阅全文... |
|